Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-23

Clinical Trial Update: Evaluating the Safety and Efficacy of the KXL System for Corneal Collagen Cross-Linking in Eyes Having Keratoconus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the safety and efficacy of the KXL System for corneal collagen cross-linking in eyes with keratoconus and post-LASIK ke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KXL System

Snippet

Sponsor: Singapore Eye Research Institute | Conditions: Keratoconus, Post LASIK Keratectasia | Phase 3 | Status: UNKNOWN